SCHEMBL32688262

SCHEMBL32688262

N#Cc1c(-c2ccc(N3CCCC3=O)cc2)cc(=O)[nH]c1SCc1nnn[nH]1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRK6 P43250 1/20 0.37
▸ HSD11B1 P28845 6/20 0.35
▸ TBK1 Q9UHD2 1/20 0.35
▸ PRKAB2 O43741 1/20 0.35
▸ PRKAG1 P54619 1/20 0.35
▸ PRKAA2 P54646 1/20 0.35
▸ PRKAA1 Q13131 1/20 0.35
▸ PRKAG3 Q9UGI9 1/20 0.35
▸ PRKAG2 Q9UGJ0 1/20 0.35
▸ PRKAB1 Q9Y478 1/20 0.35
▸ ADORA3 P0DMS8 2/20 0.34
▸ ADORA2A P29274 2/20 0.34
▸ ADORA1 P30542 2/20 0.34
▸ ADORA2B P29275 1/20 0.34
▸ F10 P00742 1/20 0.32
▸ PRSS1 P07477 1/20 0.32
▸ PRSS2 P07478 1/20 0.32
▸ PRSS3 P35030 1/20 0.32
▸ TNIK Q9UKE5 2/20 0.31
▸ EGLN2 Q96KS0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688274 0.92 BRD4 (0.38) GRK6HSD11B1TBK1ADORA3ADORA2A
SCHEMBL32688103 0.85 GRK6 (0.37) GRK6HSD11B1
SCHEMBL32688231 0.81 ALDH1A1 (0.36) HSD11B1ADORA3ADORA2AADORA1ADORA2B
SCHEMBL32688138 0.81 KMT2A (0.41) HSD11B1ADORA3ADORA2AADORA1ADORA2B
SCHEMBL32688472 0.81 GRK6 (0.36) GRK6HSD11B1ADORA3ADORA2AADORA1
SCHEMBL32688310 0.80 GRK6 (0.37) GRK6HSD11B1
SCHEMBL32688199 0.78 HSD11B1 (0.36) HSD11B1ADORA3ADORA2AADORA1ADORA2B
SCHEMBL32688163 0.78 KISS1R (0.39) GRK6
SCHEMBL32687986 0.77 KMT2A (0.39) HSD11B1ADORA3ADORA2AADORA1ADORA2B
SCHEMBL32687988 0.74 PRKAB2 (0.43) TBK1PRKAB2PRKAG1PRKAA2PRKAA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK GRK6 1411/4885HSD11B1 61/4885TBK1 2056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback